Mechanism of action-based classification of antibiotics using high-content bacterial image analysis.
暂无分享,去创建一个
Roger G Linington | Peter F Linington | Roger G. Linington | P. Linington | Walter M. Bray | Kelly C Peach | Walter M Bray | Dustin Winslow | Kelly C. Peach | Dustin Winslow
[1] Joshua M. Stuart,et al. "Function-first" lead discovery: mode of action profiling of natural product libraries using image-based screening. , 2013, Chemistry & biology.
[2] Roger G Linington,et al. Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics. , 2012, Chemistry & biology.
[3] Gerard D. Wright. Antibiotics: a new hope. , 2012, Chemistry & biology.
[4] Priscille Brodin,et al. High-content screening in infectious diseases. , 2011, Current opinion in chemical biology.
[5] Eric D Brown,et al. Antibiotics as probes of biological complexity. , 2011, Nature chemical biology.
[6] T. Oh,et al. Exceptional Production of both Prodigiosin and Cycloprodigiosin as Major Metabolic Constituents by a Novel Marine Bacterium, Zooshikella rubidus S1-1 , 2011, Applied and Environmental Microbiology.
[7] D. Manstein,et al. Inhibition of Myosin ATPase activity by halogenated pseudilins: a structure-activity study. , 2011, Journal of medicinal chemistry.
[8] Roger G. Linington,et al. An image-based 384-well high-throughput screening method for the discovery of biofilm inhibitors in Vibrio cholerae. , 2011, Molecular bioSystems.
[9] L. Silver. Challenges of Antibacterial Discovery , 2011, Clinical Microbiology Reviews.
[10] J. Collins,et al. How antibiotics kill bacteria: from targets to networks , 2010, Nature Reviews Microbiology.
[11] D. Manstein,et al. Total synthesis of pentabromo- and pentachloropseudilin, and synthetic analogues--allosteric inhibitors of myosin ATPase. , 2009, Angewandte Chemie.
[12] Stewart T. Cole,et al. High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors , 2009, PLoS pathogens.
[13] M. Fischbach,et al. New ways to squash superbugs. , 2009, Scientific American.
[14] John A. Tallarico,et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. , 2008, Nature chemical biology.
[15] Sabine Van Huffel,et al. Overview of total least-squares methods , 2007, Signal Process..
[16] D. Pompliano,et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.
[17] A. Golshani,et al. Molecular localization of a ribosome-dependent ATPase on Escherichia coli ribosomes , 2006, Nucleic acids research.
[18] J. Rohr,et al. DNA-binding properties of cosmomycin D, an anthracycline with two trisaccharide chains. , 2004, The Journal of antibiotics.
[19] H. Aoki,et al. Identification of a ribosomal ATPase in Escherichia coli cells. , 1999, Biochimie.
[20] Christopher S. Mallory,et al. Complete spectroscopic structural characterization of novobiocin, isonovobiocin, decarbamylnovobiocin, 2″-(o-Carbamyl)novobiocin, and novobiocin-2″,3″-carbonate , 1999 .
[21] R. Diaz-Arrastia,et al. Molecular and Cellular Approaches to Neural Development , 1998 .
[22] K. Yokoyama,et al. Prodigiosins uncouple mitochondrial and bacterial F-ATPases: evidence for their H+/Cl- symport activity. , 1998, Journal of biochemistry.
[23] Thomas M. Jessell,et al. Molecular and cellular approaches to neural development , 1998 .
[24] D. Wigley,et al. Molecular mechanisms of durg inhibition of DNA gyrase , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.
[25] J. Jackson,et al. Differences in mode of action of (β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy , 1996 .
[26] D. J. Mason,et al. Antibacterial action of ciprofloxacin , 1995, Antimicrobial Agents and Chemotherapy.
[27] A. Tzianabos,et al. The effect of antibiotics that inhibit cell-wall, protein, and DNA synthesis on the growth and morphology of Legionella pneumophila. , 1990, Journal of Medical Microbiology.
[28] R. Wise,et al. Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin. , 1986, The Journal of antimicrobial chemotherapy.
[29] R. H. Thomson,et al. A revised structure for cycloprodigiosin , 1983 .
[30] N. N. Gerber. Cycloprodigiosin from beneckea gazogenes , 1983 .
[31] R. Robson,et al. Morphological changes associated with novobiocin resistance in Bacillus licheniformis , 1977, Journal of bacteriology.
[32] M. Gellert,et al. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Russell,et al. Effect of the Inhibition of Protein Synthesis on the Escherichia coli Cell Envelope , 1974, Antimicrobial Agents and Chemotherapy.
[34] R. Perkins,et al. Surface Manifestations of Antibiotic-Induced Alterations in Protein Synthesis in Bacterial Cells , 1972, Antimicrobial Agents and Chemotherapy.
[35] R. Perkins,et al. Antibiotic-induced alterations in the surface morphology of bacterial cells: a scanning-beam electron miscroscopy study. , 1970, The Journal of infectious diseases.
[36] C. Watanakunakorn,et al. Induction of spheroplasts of Pseudomonas aeruginosa by carbenicillin. , 1969, Applied microbiology.
[37] W. Goss,et al. Bactericidal Action of Nalidixic Acid on Bacillus subtilis , 1966, Journal of bacteriology.